Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older who are being treated in a hematology (blood disorder) department
- People with a type of blood cancer called AML (acute myeloid leukaemia) who are well enough to receive intensive treatment, including an initial treatment phase and follow-up intensive treatment phases, which carry a high risk of lowering the body's ability to fight infection
- People who are able to give their informed consent to participate
- People who are enrolled in a social security system
Who may not be able to join:
- People under the age of 18
- People with AML who are not able to receive intensive treatment
- People who have a specific type of leukaemia called acute promyelocytic leukaemia
- People who are pregnant
- People who have HIV, hepatitis B, or hepatitis C
- People who are under legal guardianship, or whose freedom has been restricted by a court or administrative order (confirm with trial site for exact legal definitions)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0033 3 22 45 59 17
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
the arisen of EC in the CT scan
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.